Immunoglobulin expression levels as biomarker for proteasome inhibitor response
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 22, 2020
Grant Date -
Jun 23, 2016
app pub date -
Aug 8, 2014
filing date -
Aug 8, 2013
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Methods of treating a tumor in a subject and methods of determining a treatment regimen for a subject with a tumor are provided herein. In exemplary aspects, the methods comprise measuring the level of expression of immunoglobulin, FCGR2B, a gene listed in Table 4, or a combination thereof. In exemplary aspects, the subject is a subject from which a sample was obtained, wherein the level of immunoglobulin, FCGR2B, a gene listed in Table 4, or a combination thereof, has been measured from the sample. Related kits, computer readable-storage media, systems, and methods implemented by a processor in a computer are further provided.
First Claim
Other Claims data not available
Family
International Classification(s)
- 2014 Application Filing Year
- C12Q Class
- 3114 Applications Filed
- 2141 Patents Issued To-Date
- 68.76 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- C12Q Class
- 0 % this patent is cited more than
- 5 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Jun 22, 2028 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jun 22, 2032 |
